Post-ERCP pancreatitis prophylaxis: is it really that complex?

Endoscopy 2019; 51(10): 909-910
DOI: 10.1055/a-0997-3181

Editorial

Referring to Sotoudehmanesh M et al. p. 915–921

Klaus Mönkemüller

¹Division of Gastroenterology, Helios Frankenwaldklinik, Kronach, Germany

²University of Belgrade, Belgrade, Serbia

References
1 Kapral C, Mühlberger A, Wewalka F. et al. Quality assessment of endoscopic retrograde cholangiopancreatography: results of a running nationwide Austrian benchmarking project after 5 years of implementation. Eur J Gastroenterol Hepatol 2012; 24: 1447-1454
2 Dumonceau JM, Andriulli A, Elmunzer BJ. et al. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – updated June 2014. Endoscopy 2014; 46: 799-815
3 Sotoudehmanesh R, Ali-Asgari A, Khatibian M. et al. Pharmacological prophylaxis versus pancreatic duct stenting plus pharmacological prophylaxis for prevention of post-ERCP pancreatitis in high risk patients: a randomized trial. Endoscopy 2019; 51: 915-921
4 Sotoudehmanesh R, Khatibian M, Kolahdoozan S. et al. Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP. Am J Gastroenterol 2007; 102: 978-983
5 Sotoudehmanesh R, Eloubeidi MA, Asgari AA. et al. A randomized trial of rectal indomethacin and sublingual nitrates to prevent post-ERCP pancreatitis. Am J Gastroenterol 2014; 109: 903-909
6 Mariani A, Di Leo M, Giardullo N. et al. Early precut sphincterotomy for difficult biliary access to reduce post-ERCP pancreatitis: a randomized trial. Endoscopy 2016; 48: 530-535